{
  "chapter": "Headache Disorders",
  "questions": [
    {
      "q_no": 1,
      "question": "Question 1: What is the most common type of headache?",
      "options": {
        "a": "Medication overuse headache",
        "b": "Tension-type headache",
        "c": "Migraine without aura",
        "d": "Cluster headache"
      },
      "correct_answer": "b",
      "explanation": "The most common type of headache is tension-type headache (TTH). The pain of TTH can generally be managed with simple analgesics such as acetaminophen, \naspirin, or NSAIDs. For chronic TTH, amitriptyline is the only proven treatment. Causes of primary headache, in decreasing order: • Tension-type headache • Migraine • Idiopathic stabbing • Exertional • Cluster Causes of secondary headache, in decreasing order: • Systemic infection • Head injury • Vascular disorders • Subarachnoid hemorrhage 1200 \nSold by @itachibot • Brain tumor",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 2,
      "question": "Question 2: What is the most common cause of secondary headache?",
      "options": {
        "a": "Head injury",
        "b": "Systemic infection",
        "c": "Vascular disorders",
        "d": "Brain tumor"
      },
      "correct_answer": "b",
      "explanation": "The most common cause of secondary headache is a systemic infection. Causes of primary headache, in decreasing order: • Tension-type headache • Migraine • Idiopathic stabbing • Exertional • Cluster Causes of secondary headache, in decreasing order: • Systemic infection • Head injury • Vascular disorders • Subarachnoid hemorrhage • Brain tumor",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 3,
      "question": "Question 3: Which of the following case scenarios do not depict tension-type headache?",
      "options": {
        "a": "A 34-year-old woman presenting with a chronic headache for &gt;15 days per month",
        "b": "A 41-year-old man presenting with a bilateral headache lasting for 4-6 hours",
        "c": "A 38-year-old man presenting with a tight band-like discomfort around the head",
        "d": "A 34-year-old woman presenting with a pulsatile headache associated with nausea"
      },
      "correct_answer": "d",
      "explanation": "A pulsatile headache associated with nausea is not a feature of tension-type headache (TTH). Tension-type headache is a chronic head-pain syndrome characterized by bilateral, tight, \nband-like discomfort. The pain typically builds slowly, fluctuates in severity, and may persist more \nor less continuously for many days. The headache may be episodic or chronic (present &gt;15 days \nper month). Tension headache \nMigraine \nCluster headache Location \nBilateral \nUnilateral \nUnilateral Duration \n>30 min (typically 4-6 hr) \n4-72 hour \n15 min-3 hour Feature \nSteady pain \nPulsating pain \nRepetitive brief headache wit \nh excruciating periorbital pai \nn Associatio \nns Lacrimation and rhinorrhea \npresentMay present with Hor \nner syndrome Nausea, photophobia, phono \nphobia presentMay have aura No photophobia or phonoph \nobiaNo aura NSAIDs, triptans, dihydroerg \notamine Sumatriptan, 100% oxygen Treatment \nAnalgesics, NSAIDs, acetami \nnophen 1201 \nSold by @itachibot Tension headache \nMigraine \nCluster headache Amitriptyline \nLifestyle changes(eg, sleep,ex \nercise, diet)-blockersCalciu \nm channel blockersAmitripty \nline, topiramate, valproateCG \nRP antagonists - erenumab, f \nremanezumab, galcanezumab, \neptinezumab Prophylaxi \ns Verapamil",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 4,
      "question": "Question 4: A patient comes with complaints of non-pulsatile headache of tightening quality on both sides \nof his forehead. He describes it as wearing a tight cap. He has no nausea, photophobia, or \nphonophobia. All of the following drugs can be used in the treatment of this condition except",
      "options": {
        "a": "Aspirin",
        "b": "Sumatriptan",
        "c": "Acetaminophen",
        "d": "Naproxen"
      },
      "correct_answer": "b",
      "explanation": "A bilateral, non-pulsatile headache of tightening quality without any nausea or photophobia \nsuggests a diagnosis of tension-type headache (TTH). Triptans are not useful in the treatment of \nthis condition. They are useful when the patient has a migraine headache. Tension-type headache \nMigraine \nCluster headache 100% oxygenSumatri \nptan AnalgesicsNSAIDsAcetamino \nphen NSAIDsTriptansDihydroergo \ntamine Treatme \nnt Amitriptyline \nLifestyle changes(eg, sleep,ex \nercise, diet)-blockersCalciu \nm channel blockersAmitripty \nline, topiramate, valproateCG \nRP antagonists - erenumab, f \nremanezumab, galcanezumab, \neptinezumab Prophyla \nxis Verapamil",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 5,
      "question": "Question 5: A 41-year-old man has a 4-year history of severe left-sided excruciating episodic headaches. \nMost episodes are accompanied by ipsilateral lacrimation, conjunctival injection, and \nrhinorrhea. There are no cutaneous triggers. It does not respond to indomethacin and attacks \nget triggered by alcohol. What is the likely diagnosis?",
      "options": {
        "a": "Trigeminal neuralgia",
        "b": "Cluster headache",
        "c": "SUNCT",
        "d": "Paroxysmal hemicranias"
      },
      "correct_answer": "b",
      "explanation": "This patient's clinical features are suggestive of cluster headache. Patients with cluster headaches \nare more often smokers with a higher than average alcohol consumption. Cluster headache causes severe, unilateral periorbital pain with autonomic features, such as \nunilateral lacrimation, nasal congestion, and conjunctival injection. Occasionally features of \nHorner's syndrome may be seen. The pain, though severe, is characteristically brief (30–90 \nminutes). There are 1-8 attacks/day lasting for 15min-3 hours.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 6,
      "question": "Question 6: A man presents with complaints of a recurrent left-sided stabbing headache. He has been \nexperiencing this every day, along with a runny nose during the episodes, for the last week. \nThese episodes last for about an hour. Examination shows the following. Which of the \nfollowing is not used for the prophylaxis of this condition?",
      "options": {
        "a": "Verapamil",
        "b": "Indomethacin",
        "c": "Steroids",
        "d": "Lithium"
      },
      "correct_answer": "b",
      "explanation": "Repetitive brief, unilateral, stabbing headaches associated with lacrimation and rhinorrhea \nsuggest a diagnosis of cluster headaches. Indomethacin is not used for the prophylaxis of these \nheadaches. 1202 \nSold by @itachibot The drug of choice used in the prophylaxis of cluster headaches is verapamil. Steroids and lithium \ncan also be used.",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxmedicine/Headache_Disorders_Q6_q.jpg",
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 7,
      "question": "Question 7: What is the most common positive visual aura seen by patients during an attack of migraine?",
      "options": {
        "a": "Scotoma",
        "b": "Zig zag lines",
        "c": "Transient loss of vision",
        "d": "Key hole vision"
      },
      "correct_answer": "b",
      "explanation": "The most common positive visual aura seen in attacks of migraine is a zig-zag line in front of the \neyes. The most common negative visual aura is scotoma. The classic migraine is associated with an aura. The aura can be: • Visual (most common): • Zigzag lines • Tunnel vision • Scotoma • Transient visual loss • Sensory: • Tingling sensation of hands, which spreads proximally",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 8,
      "question": "Question 8: A 26-year old woman presents with a unilateral throbbing headache associated with nausea \nand vomiting. She has had similar episodes in the past where the headache usually lasts for \n1-2 days. Bright light increases her discomfort and she prefers sitting in a dark room. Which \nof the following is associated with this condition?",
      "options": {
        "a": "Interleukin 1",
        "b": "Calcitonin gene-related peptide",
        "c": "Leukotriene B4",
        "d": "Interleukin 6"
      },
      "correct_answer": "b",
      "explanation": "Multiple unilateral throbbing headache associated with nausea, vomiting and photophobia \nsuggests a diagnosis of migraine. Calcitonin gene-related peptide (CGRP) is a vasoactive \nneuropeptide associated with this condition. It is present at vascular terminations of the \ntrigeminal nerve and within the trigeminal nucleus. CGRP antagonists approved for migraine prevention are: • Erenumab • Fremanezumab • Galcanezumab • Eptinezumab 1203 \nSold by @itachibot Note: The FDA has recently approved Atogepant, a calcitonin gene-related peptide (CGRP) receptor \nantagonist for the preventive treatment of episodic migraine in adults. The recommended dosage \nis 10 mg, 30 mg, or 60 mg orally once daily. In severe renal impairment or end-stage renal disease \nit is 10 mg once daily.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 9,
      "question": "Question 9: In patients with familial hemiplegic migraine, which of the following is least likely to be \ndefective?",
      "options": {
        "a": "Voltage-gated calcium channel gene",
        "b": "Sodium potassium ATPase gene",
        "c": "Voltage gated sodium channel",
        "d": "Voltage gated chloride channel"
      },
      "correct_answer": "d",
      "explanation": "Familial hemiplegic migraine (FHM) is due to defective voltage-gated calcium channel gene, \nsodium-potassium ATPase gene, and voltage-gated sodium channel. The voltage-gated chloride \nchannel is not defective in this condition. Type \nMutation FHM Voltage-gated calcium chann \nel (CACNAIA)gene 1 FHM Sodium -potassium ATPase ( \nATPIA2) gene 2 FHM Voltage-gated sodium channe \nl (SCNIA) 3",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 10,
      "question": "Question 10: A 23-year-old woman experiences severe throbbing headaches on the right side of her \nforehead. Soon after the headache begins, she becomes very nauseous and occasionally gets 1196 \nSold by @itachibot dizzy. She has also vomited multiple times during these episodes and is subsequently \ndiagnosed with severe migraine. Which among the following is the most efficacious triptan \nused to treat this condition?",
      "options": {
        "a": "Sumatriptan",
        "b": "Rizatriptan",
        "c": "Frovotriptan",
        "d": "Naratriptan"
      },
      "correct_answer": "b",
      "explanation": "The most efficacious triptans for moderate to severe acute migraines are rizatriptan and \neletriptan. Oral dosage forms of triptans are the most convenient to use. Still, they may not be practical in \npatients experiencing migraine-associated nausea and vomiting, for whom injectable and nasal 1204 \nSold by @itachibot spray formulations are helpful. Standard treatment comprises a 6-mg subcutaneous dose of sumatriptan. All triptans have similar \npharmacologic properties but vary slightly in terms of clinical efficacy. Rizatriptan and eletriptan \nare the most efficacious of the triptans currently available.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 11,
      "question": "Question 11: A young woman has been suffering from 1-2 episodes of migraine every week. These episodes \nare affecting her quality of life. All of the following drugs can be used in the prophylaxis of \nmigraine in this patient except",
      "options": {
        "a": "Propranolol",
        "b": "Amitriptyline",
        "c": "Sumatriptan",
        "d": "Valproate"
      },
      "correct_answer": "c",
      "explanation": "Sumatriptan is used in the treatment of an acute attack of migraine not in prophylaxis. It can be \ngiven by oral, subcutaneous, intravenous or intranasal routes. Drugs used in the prophylaxis of migraine: • Beta-blockers- propranolol • Calcium channel blocker- flunarizine (verapamil, nimodipine has no role) • Antidepressants- amitriptyline, venlafaxine (SSRIs like fluoxetine are not used) • Anticonvulsants- valproate, topiramate • 5-HT2 antagonist- pizotifen • CGRP antagonists - erenumab, framanezumab, galcanezumab, eptinezumab Other modalities of preventative treatment: • Greater occipital nerve block • Onabotulinum toxin A • Supraorbital transcutaneous stimulation",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 12,
      "question": "Question 12: Sumatriptan can be given in which of the following patients diagnosed with migraine?",
      "options": {
        "a": "A 42-year-old woman who had taken ergot alkaloids in the past one week",
        "b": "A 34-year-old woman presenting with a positive urine pregnancy test",
        "c": "A 48-year-old man with a history of cerebrovascular disease",
        "d": "A 51-year-old man with a history of coronary artery disease"
      },
      "correct_answer": "a",
      "explanation": "Taking ergot alkaloids in the past one week is not a contraindication for sumatriptan. However, \nthey shouldn't be given together as doing so could result in excessive blood vessel narrowing. Ergots constrict arteries and triptans narrow normal heart arteries by up to 20%. For this reason, \nergots should not be taken with triptans on the same day. Sumatriptan is a 5HT1B/1D receptor agonist used in an acute migraine attack. It is \ncontraindicated in the following conditions: • Cerebrovascular disease • Coronary artery disease Option B- Sumatriptan is the safest triptan in pregnancy, but its use is recommended only if the \nbenefits outweigh the risks, and if all first line options do not provide relief.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 13,
      "question": "Question 13: What is the use of MIDAS questionnaire?",
      "options": {
        "a": "To assess severity of migraine",
        "b": "To assess disability of migraine",
        "c": "To help decide treatment of migraine",
        "d": "To assess risk of migraine"
      },
      "correct_answer": "b",
      "explanation": "1205 \nSold by @itachibot The Migraine Disability Assessment Score (MIDAS) questionnaire was put together to help \nmeasure the impact of migraine on patients' lives.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 14,
      "question": "Question 14: Which of the following is used in the preventive treatment of a patient with chronic migraine?",
      "options": {
        "a": "Onabotulinum toxin A",
        "b": "Sumatriptan",
        "c": "Metoclopramide",
        "d": "Ergotamine"
      },
      "correct_answer": "a",
      "explanation": "Onabotulinum toxin A is used in the preventive treatment of patients with chronic migraine. Sumatriptan, ergotamine, and metoclopramide are used in the treatment of an acute attack of \nmigraine. Drugs used in the prophylaxis of migraine: • Beta-blockers- propranolol • Calcium channel blocker- flunarizine (verapamil, nimodipine has no role) • Antidepressants- amitriptyline, venlafaxine (SSRIs like fluoxetine are not used) • Anticonvulsants- valproate, topiramate • 5-HT2 antagonist- pizotifen • CGRP antagonists - erenumab, framanezumab, galcanezumab, eptinezumab Other modalities of preventative treatment: • Greater occipital nerve block • Onabotulinum toxin A • Supraorbital transcutaneous stimulation",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 15,
      "question": "Question 15: Which of the following is not a trigeminal autonomic cephalalgia?",
      "options": {
        "a": "Cluster headache",
        "b": "SUNA",
        "c": "Hemicrania continua",
        "d": "Nummular headache"
      },
      "correct_answer": "d",
      "explanation": "Nummular headache is not a trigeminal autonomic cephalalgia. It is characterized by small \ncircumscribed areas of continuous pain on the head. Trigeminal autonomic cephalalgia is characterized by pain along the distribution of trigeminal \nnerve (unilateral) and cranial autonomic symptoms. This is due to increased parasympathetic flow \nand decreased sympathetic flow.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 16,
      "question": "Question 16: All are true about patients with trigeminal autonomic cephalgia except:",
      "options": {
        "a": "Cluster headache is more common in males",
        "b": "SUNCT has highest attack frequency rate",
        "c": "Lidocaine is effective in SUNCT",
        "d": "Cutaneous trigger is seen in cluster headache"
      },
      "correct_answer": "d",
      "explanation": "The cutaneous trigger is not seen in cluster headache. It is seen in short-lasting unilateral \nneuralgiform headache with conjunctival injection and tearing (SUNCT).",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 17,
      "question": "Question 17: A patient was prescribed indomethacin for his complaint of headache and he felt relief after \ntaking the drug. Which of the following could be a likely diagnosis?",
      "options": {
        "a": "Paroxysmal hemicrania",
        "b": "Cluster headache",
        "c": "SUNCT",
        "d": "Trigeminal neuralgia"
      },
      "correct_answer": "a",
      "explanation": "1206 \nSold by @itachibot Paroxysmal hemicrania could be the likely diagnosis since it responds to indomethacin. It is characterized by frequent unilateral, severe, short-lasting, and frequent episodes of headache. \nThey have marked autonomic features ipsilateral to the pain. Indomethacin (25–75 mg t.i.d) can completely suppress attacks of paroxysmal hemicrania. It is \nalso effective in: • Hemicrania continuum • Primary sexual / exercise headache • Tension-type headache",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 18,
      "question": "Question 18: A 40-year-old male is diagnosed to have SUNCT. It can be distinguished from trigeminal \nneuralgia by the presence of all except:",
      "options": {
        "a": "Excessive lacrimation",
        "b": "Nasal congestion",
        "c": "Conjuctival injection",
        "d": "Short attacks of stabbing pain"
      },
      "correct_answer": "d",
      "explanation": "Short attacks of stabbing pain are common to both SUNCT and trigeminal neuralgia. SUNCT has autonomic symptoms such as lacrimation, nasal congestion, conjunctival injection, \nand salivation. Trigeminal neuralgia does not have autonomic symptoms.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 19,
      "question": "Question 19: All are true about patients with trigeminal neuralgia except:",
      "options": {
        "a": "More common in females",
        "b": "Pain along V2 and V3 division of trigeminal nerve",
        "c": "Deep seated pain",
        "d": "No objective signs of sensory loss"
      },
      "correct_answer": "c",
      "explanation": "Trigeminal neuralgia is associated with superficial pain and not deep-seated pain. It is more common (~ 60% of cases) in females (Option A) over 50 years and is characterized by \nunilateral lancinating facial pain. This most commonly involves the second and/or third divisions \n(Option B) of the trigeminal nerve territory. Bilateral or early-onset pain is associated with \nmultiple sclerosis. Unilateral trigeminal nerve compression can be due to the superior cerebellar \nartery. Pain is repetitive, severe, and brief and can be triggered by touch, cold, wind, or eating. Physical \nsigns are usually absent, although the spasms may make the patient wince and sit silently (tic \ndouloureux). No signs of sensory loss are present (Option D) The drug of choice is carbamazepine. Note: It is important to note that trigeminal neuralgia and trigeminal autonomic cephalalgia \n(TAC) are different entities. TAC is a group of primary headaches that include - cluster headaches, \nparoxysmal hemicrania, short-lasting unilateral neuralgiform headache attacks with conjunctival \ninjection and tearing (SUNCT)/short-lasting unilateral neuralgiform headache attacks with cranial \nautonomic symptoms (SUNA), and hemicrania continua.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Headache Disorders"
    },
    {
      "q_no": 20,
      "question": "Question 20: A 42-year-old man presented with an extremely painful headache that came on suddenly \nwithout warning. It reached maximum intensity within 1 minute and lasted for 5 minutes. \nWhich of the following would you not include as a differential?",
      "options": {
        "a": "Leucine-rich repeat kinase 2",
        "b": "Parkin",
        "c": "Alpha-synuclein gene missense mutation",
        "d": "PTEN-induced putative kinase 1"
      },
      "correct_answer": "a",
      "explanation": "The given clinical scenario is suggestive of a thunderclap headache. Subdural hemorrhage will not \nproduce this type of headache. Causes of thunderclap headache: 1207 \nSold by @itachibot • Subarachnoid hemorrhage • Acute hydrocephalus • Pituitary apoplexy • Cerebral venous thrombosis • Hypertensive crisis 1208 \nSold by @itachibot Movement Disorders",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxmedicine/Headache_Disorders_Q20_q.jpg",
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/mxmedicine/Headache_Disorders_Q20_exp.jpg",
      "chapter_heading": "Headache Disorders"
    }
  ]
}
